• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The THELEP controlled clinical drug trials. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP). Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.

出版信息

Int J Lepr Other Mycobact Dis. 1987 Dec;55(4 Suppl):864-71.

PMID:3325580
Abstract
摘要

相似文献

1
The THELEP controlled clinical drug trials. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP). Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.麻风病化疗临床试验小组（THELEP）。麻风病化疗临床试验小组委员会（THELEP）。联合国开发计划署/世界银行/世界卫生组织热带病研究和培训特别规划科学工作组。
Int J Lepr Other Mycobact Dis. 1987 Dec;55(4 Suppl):864-71.
2
Primary dapsone resistance in Bamako and Chingleput: final report; THELEP. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.巴马科和金奈珀特的氨苯砜原发性耐药性：最终报告；麻风病化疗临床试验小组委员会（THELEP），联合国开发计划署/世界银行/世界卫生组织热带病研究和培训特别规划科学工作组
Lepr Rev. 1987 Sep;58(3):209-18.
3
Persisting Mycobacterium leprae among THELEP trial patients in Bamako and Chingleput. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.巴马科和金奈普勒特的THELEP试验患者中持续存在的麻风分枝杆菌。联合国开发计划署/世界银行/世卫组织热带病研究和培训特别规划麻风病化疗临床试验小组委员会（THELEP）科学工作组
Lepr Rev. 1987 Dec;58(4):325-37.
4
Characteristics of the multiplication of dapsone-resistant strains of Mycobacterium leprae in mice. Subcommittee on Clinical Trials of the C hemotherapy of Leprosy (THELEP) Scientific Working Group of UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.小鼠体内耐氨苯砜麻风分枝杆菌增殖的特征。联合国开发计划署/世界银行/世界卫生组织热带病研究和培训特别规划麻风病化疗临床试验小组委员会（THELEP）科学工作组。
Lepr Rev. 1988 Mar;59(1):5-10.
5
Characteristics of patients in the THELEP trials of chemotherapy of leprosy at Bamako and Chingleput. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.巴马科和金奈普勒麻风病化疗THELEP试验患者的特征。联合国开发计划署/世界银行/世界卫生组织热带病研究和培训特别规划麻风病化疗临床试验小组委员会（THELEP）科学工作组。
Lepr Rev. 1987 Mar;58(1):7-16.
6
Response to treatment by multidrug regimens in the THELEP controlled clinical drug trials. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.在THELEP对照临床药物试验中对多药治疗方案的反应。联合国开发计划署/世界银行/世界卫生组织热带病研究和培训特别规划麻风病化疗临床试验小组委员会（THELEP）科学工作组。
Lepr Rev. 1996 Dec;67(4):260-79.
7
Report of the Third Meeting of the Scientific Working Group on Chemotherapy of Leprosy (THELEP) of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, Geneva, 20-22 October 1980.联合国开发计划署/世界银行/世界卫生组织热带病研究和培训特别规划麻风病化疗科学工作组第三次会议报告，日内瓦，1980年10月20 - 22日
Lepr Rev. 1981 Dec;52(4):349-54. doi: 10.5935/0305-7518.19810046.
8
The prevalence of folP1 mutations associated with clinical resistance to dapsone, in Mycobacterium leprae isolates from South Korea.韩国麻风分枝杆菌分离株中与临床耐氨苯砜相关的folP1突变的流行情况。
Ann Trop Med Parasitol. 2001 Jun;95(4):429-32. doi: 10.1080/000349801300188447.
9
Drug resistant leprosy--a comparison between proven dapsone and proven thiambutosine resistance.耐药性麻风病——氨苯砜耐药与氨硫脲耐药的比较
Int J Lepr Other Mycobact Dis. 1976 Jan-Jun;44(1-2):152-3.
10
Committee 4: workshop on experimental chemotherapy of leprosy.委员会4：麻风病实验化疗研讨会
Int J Lepr Other Mycobact Dis. 1979 Jun;47(2 Suppl):297-303.